Афлубин®

General characteristics. Structure:

Active ingredients: 3,6 mg of a gentian (Gentiana) D1, 37,2 mg of monk's-hood (Aconitum) D6 - 37,2 mg, 37,2 mg of a bryony (Bryonia) D6, 37,2 mg of iron phosphate (Ferrum phosphoricum) D12, 37,2 mg of lactic acid (Acidum sarcolacticum) D12.

Excipients: lactoses monohydrate, potato starch, magnesium stearate.

Natural complex drug for prevention and treatment of cold and flu, for adults and children since the first year of life

Pharmacological properties:

Pharmacodynamics. Complex homeopathic medicine. Renders antiinflammatory, immunomodulatory, febrifugal, disintoxication action. Has antiviral activity. Promotes increase in activity of nonspecific factors of local immunity. Reduces intensity and duration of intoksikatsionny and catarral syndromes, normalizes functions of a mucous membrane of respiratory tracts.
 
Pharmacokinetics. Effect of drug Aflubin is result of cumulative action of its components therefore carrying out kinetic observations is not possible; everything together components cannot be tracked by means of markers or bioresearches. For the same reason it is impossible to find also metabolites of drug.

Indications to use:

In complex treatment of flu, parainfluenza and acute respiratory diseases for the purpose of relief of symptoms of the specified diseases, and also for their prevention both planned, and emergency.

For treatment of the inflammatory and rheumatic diseases which are followed by a joint pain syndrome.

Route of administration and doses:

Age	Dose (one-time)	Frequency rate of reception	Route of administration
1 - 2 day of a disease of ORZ or flu
Adults and teenagers	1 tablet	From 3 to 8 times a day (no more)	in 30 minutes prior to or in 1 hour after food
Children up to 12 years	½ tablets	From 3 to 8 times a day (no more)	in 30 minutes prior to or in 1 hour after food
Children till 1 year	½ tablets	From 3 to 8 times a day (no more)	to part in 1 teaspoon of water or maternal milk, to give on 1 drop in 30 minutes prior to or in 1 hour after feeding
Further treatment of clinical manifestations of ORZ or flu
Adults and teenagers	1 tablet	3 times a day. 5-10 days	in 30 minutes prior to or in 1 hour after food
Children up to 12 years	½ tablets	3 times a day. 5-10 days	in 30 minutes prior to or in 1 hour after food
Children till 1 year	½ tablets	3 times a day. 5-10 days	to part in 1 teaspoon of water or maternal milk, to give on 1 drop in 30 minutes prior to or in 1 hour after feeding
Planned prevention of an exacerbation of a disease at the beginning of cold season or before a flu epidemic
Adults and teenagers	1 tablet	2 times a day. 3 weeks	in 30 minutes prior to or in 1 hour after food
Children up to 12 years	½ tablets	2 times a day. 3 weeks	in 30 minutes prior to or in 1 hour after food
Children till 1 year	½ tablets	2 times a day. 3 weeks	to part in 1 teaspoon of water or maternal milk, to give on 1 drop in 30 minutes prior to or in 1 hour after feeding
The emergency prevention – is carried out at once after contact with sick flu or ORZ or after strong overcooling
Adults and teenagers	1 tablet	2 times a day. 2 days	in 30 minutes prior to or in 1 hour after food.
Children up to 12 years	½ tablets	2 times a day. 2 days	in 30 minutes prior to or in 1 hour after food
Children till 1 year	½ tablets	2 times a day. 2 days	to part in 1 teaspoon of water or maternal milk, to give on 1 drop in 30 minutes prior to or in 1 hour after feeding
Treatment of the inflammatory and rheumatic diseases which are followed by a joint pain syndrome
Adults and teenagers	1 tablet	3-8 times a day in an initiation of treatment (1-2 days), further treatment 3 times a day within 1 month	in 30 minutes prior to or in 1 hour after food
Children up to 12 years	½ tablets	3-8 times a day in an initiation of treatment (1-2 days), further treatment 3 times a day within 1 month	in 30 minutes prior to or in 1 hour after food

 

Features of use:

Use at pregnancy and in the period of a lactation: at pregnancy and in the period of a lactation drug is used on doctor's orders.

Side effects:

Currently emergence of side effects is not registered.

Interaction with other medicines:

Clinically significant interaction of drug with other medicines is not established.

Contraindications:

Hypersensitivity to drug components.

Overdose:

Overdose cases were not registered so far.

Storage conditions:

At a temperature not above 25 °C in the place protected from light. To store in the places unavailable to children. Period of storage 3 years. Not to apply after the period of validity specified on packaging.

Issue conditions:

Without recipe

Packaging:

On 12 tablets in the blister from aluminum foil and PVH/PVDH. On 1, 2, 3 or 4 blisters place together with the instruction on a medical use in a cardboard pack.